Dr. David Brennan, DO

NPI: 1013414952
Total Payments
$1,278
2022 Payments
$266.64
Companies
10
Transactions
26
Medicare Patients
427
Medicare Billing
$43,622

Payment Breakdown by Category

Food & Beverage$1,278 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,278 26 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $387.99 7 $0 (2022)
Alexion Pharmaceuticals, Inc. $178.74 3 $0 (2022)
E.R. Squibb & Sons, L.L.C. $159.74 2 $0 (2020)
La Jolla Pharmaceutical Company $121.69 2 $0 (2020)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $120.05 4 $0 (2021)
BTG INTERNATIONAL, INC. $89.32 1 $0 (2020)
Janssen Pharmaceuticals, Inc $72.28 2 $0 (2021)
PFIZER INC. $64.06 2 $0 (2020)
Melinta Therapeutics, LLC $50.88 2 $0 (2022)
ABIOMED $33.07 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $266.64 6 AstraZeneca Pharmaceuticals LP ($112.18)
2021 $399.76 10 AstraZeneca Pharmaceuticals LP ($157.93)
2020 $248.19 5 BTG INTERNATIONAL, INC. ($89.32)
2019 $363.23 5 E.R. Squibb & Sons, L.L.C. ($107.68)

All Payment Transactions

26 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/18/2022 Melinta Therapeutics, LLC Kimyrsa (Drug), Vabomere, Orbactiv Food and Beverage In-kind items and services $31.23 General
Category: ANTIBIOTICS
09/27/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $36.22 General
Category: Rare Disease
09/13/2022 ABIOMED Impella (Device) Food and Beverage In-kind items and services $33.07 General
Category: Cardiology/Vascular Diseases
05/12/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $34.29 General
Category: Rare Disease
05/11/2022 Melinta Therapeutics, LLC Kimyrsa (Drug), Orbactiv, Vabomere Food and Beverage In-kind items and services $19.65 General
Category: ANTIBIOTICS
04/14/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $112.18 General
Category: Rare Disease
11/12/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $80.05 General
Category: Gastroenterology
10/06/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $13.83 General
Category: Gastroenterology
09/16/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.36 General
Category: Cardiovascular and Metabolism
09/08/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $12.66 General
Category: Gastroenterology
08/12/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.55 General
Category: Cardiovascular & Metabolism
07/22/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.36 General
Category: Cardiovascular and Metabolism
07/08/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $108.23 General
Category: Hematology
05/20/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $13.51 General
Category: Gastroenterology
05/13/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $118.27 General
Category: Cardiovascular and Metabolism
03/05/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $12.94 General
Category: Cardiovascular and Metabolism
12/05/2020 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $16.31 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/27/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $11.94 General
Category: Cardiovascular and Metabolism
03/12/2020 BTG INTERNATIONAL, INC. CROFAB (Drug) Food and Beverage Cash or cash equivalent $89.32 General
Category: ANTI-VENOM
02/13/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $52.06 General
Category: Cardiovascular
01/09/2020 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $78.56 General
Category: EMERGENT HYPOTENSION
09/12/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $105.94 General
Category: Cardiovascular and Metabolism
08/08/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $47.75 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/11/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $107.68 General
Category: Cardiovascular
04/11/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $58.73 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 220 224 $215,565 $25,001
2022 3 118 119 $131,550 $11,842
2021 4 78 80 $53,552 $5,283
2020 1 11 11 $18,579 $1,495
Total Patients
427
Total Services
434
Medicare Billing
$43,622
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 77 78 $92,180 $10,534 11.4%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 88 91 $70,050 $8,306 11.9%
99291 Critical care, first 30-74 minutes Facility 2023 29 29 $41,737 $4,743 11.4%
99283 Emergency department visit with low level of medical decision making Facility 2023 26 26 $11,598 $1,418 12.2%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 50 50 $76,667 $6,986 9.1%
99284 Emergency department visit for problem of high severity Facility 2022 30 31 $32,398 $2,856 8.8%
99283 Emergency department visit for problem of moderate severity Facility 2022 38 38 $22,485 $2,000 8.9%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 16 16 $24,672 $2,267 9.2%
99284 Emergency department visit, problem of high severity Facility 2021 18 19 $17,038 $1,737 10.2%
99283 Emergency department visit, moderately severe problem Facility 2021 20 20 $10,154 $1,125 11.1%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 24 25 $1,688 $154.56 9.2%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 11 11 $18,579 $1,495 8.0%

About Dr. David Brennan, DO

Dr. David Brennan, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2018. The National Provider Identifier (NPI) number assigned to this provider is 1013414952.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brennan, DO has received a total of $1,278 in payments from pharmaceutical and medical device companies, with $266.64 received in 2022. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,278).

As a Medicare-enrolled provider, Brennan has provided services to 427 Medicare beneficiaries, totaling 434 services with total Medicare billing of $43,622. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Student in an Organized Health Care Education/Training Program
  • Location Oklahoma City, OK
  • Active Since 04/08/2018
  • Last Updated 04/30/2020
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1013414952

Products in Payments

  • LOKELMA (Drug) $275.81
  • ELIQUIS (Drug) $223.80
  • ANDEXXA (Biological) $182.69
  • GIAPREZA (Drug) $121.69
  • RELISTOR (Drug) $120.05
  • Andexxa (Drug) $108.23
  • CROFAB (Drug) $89.32
  • XARELTO (Drug) $72.28
  • Kimyrsa (Drug) $50.88
  • Impella (Device) $33.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Oklahoma City